Provectus Biopharmaceuticals Inc.

354 articles about Provectus Biopharmaceuticals Inc.

• Provectus Pharmaceuticals Inc. Receives US Patent Providing Further Protection for Novel Agent PH-12

  6/10/2008

• Provectus Pharmaceuticals Inc. Appoints Kelly M. McMasters, MD, PhD, to Board of Directors

  6/3/2008

• Provectus Pharmaceuticals Inc. Begins Phase 2 Clinical Trial for Atopic Dermatitis

  5/28/2008

• Provectus Pharmaceuticals Inc. to Present at the 34th Annual Scientific Conference of the American Society of Photobiology

  5/22/2008

• Provectus Pharmaceuticals Inc. Will Present at Inaugural LD MICRO Conference

  4/23/2008

• Provectus Pharmaceuticals Inc. Receives Patent Allowance in the EU for PH-10 Dermatology Agent

  4/15/2008

• Provectus Pharmaceuticals Inc. Announces Financial Results for Year End 2007

  3/31/2008

• Provectus Pharmaceuticals Inc. Receives US Patent Allowance to Provide Further Protection for Novel Photodynamic Drug PH-12

  3/4/2008

• Provectus Pharmaceuticals Inc. Granted China Patent for Imaging Drug

  2/27/2008

• Provectus Pharmaceuticals Inc. Receives Patent Allowances in Europe and China

  2/26/2008

• Provectus Pharmaceuticals Inc. Receives Patent Allowance in India

  1/14/2008

• Provectus Pharmaceuticals Inc. CEO Craig Dees, PhD Issues Executive Overview Letter

  1/9/2008

• Provectus Pharmaceuticals Inc. Adds Second Center to Phase 2 Clinical Trial of PV-10

  12/18/2007

• Provectus Pharmaceuticals Inc. Receives Patent in India for Lead Oncology Product

  12/11/2007

• Provectus Pharmaceuticals Inc. Receives Patent Allowance from U.S. Patent and Trademark Office

  12/5/2007

• Provectus Pharmaceuticals Inc. Phase 2 Clinical Trial Opens for Psoriasis Patients

  11/27/2007

• Provectus Pharmaceuticals Inc. Phase 2 Clinical Trial Opens for Psoriasis Patients

  11/27/2007

• Provectus Pharmaceuticals Inc. Begins Phase 2 Clinical Trial for Psoriasis

  11/13/2007

• Provectus Pharmaceuticals Inc. Receives Patent Protection Notice From U.S. Patent Office

  10/17/2007

• Provectus Pharmaceuticals Inc. to Present at the Second Annual AG Edwards 2007 Emerging Growth Conference on September 18

  9/12/2007